A Systematic Review of Spironolactone Nano-Formulations for Topical Treatment of Skin Hyperandrogenic Disorders and Chronic Wounds
<b>Background/Objectives:</b> Spironolactone (SP), an aldosterone inhibitor widely used to treat androgen-dependent disorders such as acne, hirsutism, and alopecia, has demonstrated therapeutic potential in both oral and topical formulations. However, SP’s low solubility and poor bioavai...
Saved in:
Main Authors: | Saedah Dereiah, Muhammad Usman Ghori, Barbara R. Conway |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/17/1/27 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical and Trichoscopic Evaluations of Topical Finasteride 1%, Topical Spironolactone 5%, and Minoxidil 5% in Female Pattern Hair Loss Treatment
by: Naglaa Mohamed El Sayed, et al.
Published: (2025-01-01) -
Transdermal patches: Design and current approaches to painless drug delivery
by: Al Hanbali Othman A., et al.
Published: (2019-06-01) -
Development and Characterization of a Hydrogel Containing Chloramphenicol-Loaded Binary Ethosomes for Effective Transdermal Permeation and Treatment Acne in Rat Model
by: Liu RJ, et al.
Published: (2025-02-01) -
Recent Trends in the Development and Application of Nano-Antioxidants for Skin-Related Disease
by: Yi Xue, et al.
Published: (2024-12-01) -
Cathelicidins: Opportunities and Challenges in Skin Therapeutics and Clinical Translation
by: Lenka Dzurová, et al.
Published: (2024-12-01)